NorthCoast Asset Management LLC
Source: SEC Form 13F · as of Mar 2026NorthCoast Asset Management LLC holds 25 biotech & pharma companies tracked by BioSniper, totaling $258.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
25
Total value held
$258.0M
| Company | Shares | Value |
|---|---|---|
| GMOptec International, Inc. | 554,944 | $41.3M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 90,885 | $40.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 127,743 | $34.6M |
| BMYBRISTOL MYERS SQUIBB CO | 543,470 | $33.0M |
| MCKMcKesson Corporation | 29,663 | $25.7M |
| CAHCardinal Health Inc. | 119,549 | $25.3M |
| CORCencora Inc. | 38,343 | $12.0M |
| MRKMerck & Co., Inc. | 66,758 | $8.0M |
| JNJJOHNSON & JOHNSON | 29,332 | $7.2M |
| LLYELI LILLY & Co | 5,801 | $5.3M |
| BIIBBIOGEN INC. | 20,940 | $3.8M |
| PMPhilip Morris International Inc | 18,124 | $3.0M |
| INCYIncyte Corp. | 31,820 | $3.0M |
| ZTSZoetis Inc. | 20,066 | $2.4M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 35,585 | $2.0M |
| ABTABBOTT LABORATORIES | 18,454 | $1.9M |
| ABBVAbbVie Inc. | 7,181 | $1.6M |
| GEHCGE HealthCare Technologies Inc. | 21,397 | $1.5M |
| ARGXARGENX SE | 2,034 | $1.5M |
| AMGNAMGEN INC | 3,373 | $1.2M |
| PRCTPROCEPT BioRobotics Corporation | 32,498 | $813K |
| GILDGILEAD SCIENCES, INC. | 5,738 | $800K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,958 | $648K |
| REGNREGENERON PHARMACEUTICALS, INC. | 757 | $585K |
| PFEPFIZER INC | 11,433 | $321K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.